| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 227,3 k € | +58.9% | 143,1 k € | -0.9% | 144,4 k € | +84.2% | 78,4 k € | -33.9% | 118,6 k € | +50.4% | 78,9 k € | -47.1% | 149,2 k € | +45.7% | 102,4 k € | +134.5% | 43,7 k € | -80.1% | 219,3 k € | +234.8% | 65,5 k € | +31.4% | 49,9 k € | +41.2% | 35,3 k € | |
| EBITDA | 227,1 k € | +59.0% | 142,8 k € | -0.8% | 144,0 k € | +84.0% | 78,3 k € | -33.9% | 118,4 k € | +50.5% | 78,7 k € | -44.2% | 140,9 k € | +37.8% | 102,3 k € | +134.8% | 43,6 k € | -80.1% | 219,3 k € | +234.8% | 65,5 k € | +31.4% | 49,9 k € | +41.2% | 35,3 k € | |
| Operating profit | 223,2 k € | +60.8% | 138,8 k € | -1.3% | 140,6 k € | +122.1% | 63,3 k € | -39.0% | 103,8 k € | +61.8% | 64,2 k € | -49.6% | 127,2 k € | +42.9% | 89,0 k € | +159.3% | 34,3 k € | -83.6% | 210,0 k € | +278.7% | 55,4 k € | +43.1% | 38,8 k € | +21.3% | 31,9 k € | |
| Profit/loss | 162,5 k € | +64.7% | 98,7 k € | -1.4% | 100,1 k € | +123.8% | 44,7 k € | -47.6% | 85,4 k € | +87.3% | 45,6 k € | -53.1% | 97,1 k € | +76.5% | 55,0 k € | +149.7% | 22,0 k € | -83.4% | 133,1 k € | +149.2% | 53,4 k € | +19.4% | 44,7 k € | +52.3% | 29,4 k € | |
| Equity | 520,4 k € | +22.5% | 424,7 k € | +11.5% | 381,1 k € | +25.3% | 304,0 k € | -7.6% | 328,9 k € | +14.9% | 286,2 k € | +18.2% | 242,2 k € | +37.7% | 175,9 k € | +45.5% | 120,9 k € | +22.3% | 98,9 k € | +221.7% | 30,7 k € | +1.0% | 30,4 k € | +0.4% | 30,3 k € | |
| Total assets | 572,7 k € | +21.8% | 470,2 k € | +12.6% | 417,5 k € | +23.6% | 337,9 k € | -17.3% | 408,8 k € | +22.3% | 334,1 k € | -13.1% | 384,6 k € | +35.7% | 283,4 k € | +82.6% | 155,2 k € | -42.0% | 267,4 k € | +52.7% | 175,1 k € | +38.9% | 126,1 k € | +5.1% | 120,0 k € | |
| Cash | 135,5 k € | +16.7% | 116,1 k € | -70.8% | 398,1 k € | +21.6% | 327,3 k € | -15.6% | 387,9 k € | +29.5% | 299,5 k € | -11.4% | 338,0 k € | +49.6% | 225,9 k € | +61.5% | 139,9 k € | -42.0% | 241,1 k € | +70.5% | 141,4 k € | +60.0% | 88,4 k € | -23.1% | 114,9 k € | |
| Debts | 52,2 k € | +15.0% | 45,4 k € | +24.6% | 36,5 k € | +7.8% | 33,8 k € | -57.6% | 79,8 k € | +66.5% | 47,9 k € | -65.9% | 140,6 k € | +30.9% | 107,4 k € | +217.0% | 33,9 k € | -79.9% | 168,5 k € | +16.7% | 144,3 k € | +51.2% | 95,5 k € | +6.5% | 89,7 k € | |
Private limited company · Ingelmunster · incorporated on 23/07/2002
Private limited company profitable and well capitalised. Cash position rising (+16.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER FRANCESKA DEDEURWAERDERE is a Private limited company incorporated in 2002. Its main activity is: Other human health activities. Its registered office is in Ingelmunster.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette